已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Impact of metformin, statins, and beta blockers on survival in patients with primary ovarian cancer: combined analysis of four prospective trials of AGO-OVAR and ENGOT/GCIG collaborators

医学 内科学 二甲双胍 卵巢癌 肿瘤科 妇科 癌症 胰岛素
作者
Dominik Denschlag,Florian Heitz,Jacobus Pfisterer,Darja Tutschkow,Alexander Reuß,Werner Meier,Philipp Harter,Pauline Wimberger,Mansoor Raza Mirza,Isabelle Ray‐Coquard,Giovanni Scambia,Jae‐Weon Kim,N. Colombo,Ana Oaknin,Jalid Sehouli,Kristina Lindemann,Coriolan Lebreton,Michael Eichbaum,Stefan Spiegelberg,Hannah Woopen
出处
期刊:International Journal of Gynecological Cancer [BMJ]
卷期号:34 (12): 1914-1923 被引量:1
标识
DOI:10.1136/ijgc-2024-005663
摘要

The aim of this study was to investigate the association of co-medication with metformin, a statin, or beta blocker with survival in patients with primary ovarian cancer. Individual data from three phase III, randomized controlled trials (AGO-OVAR 11, AGO-OVAR 12, and AGO-OVAR 16) and one phase II trial (AGO-OVAR 15) were pooled and analyzed. Patients were classified as ever user if the specific co-medication was documented at least once during the trial, and were compared with never users as controls. Association of co-medications and outcomes were adjusted for potential confounders (age, International Federation of Gynecology and Obstetrics stage, histology, residual disease after surgery, Eastern Cooperative Oncology Group (ECOG) performance status, body mass index, Charlson Comorbidity Index, and assigned treatment within the trial) in multivariate Cox regression analyses. Overall, n=2857 patients were included. Ever users were: 100 patients received metformin (3.5%), 226 patients received statins (7.9%), and 475 (16.6%) patients received beta blockers (n=391 selective beta blockers; 84 non-selective beta blockers) as co-medication. There were no significant differences regarding the baseline characteristics except that ever users were significantly older, more obese, and had more comorbidities, according to the Charlson Comorbidity Index, compared with controls. Multivariate analyses for progression free survival and overall survival revealed neither a significant impact of metformin on survival (progression free survival hazard ratio (HR) 0.94, 95% confidence interval CI 0.69 to 1.29, p=0.7; overall survival HR 0.82, 95% CI 0.58 to 1.17, p=0.28) nor for statins (progression free survival HR 0.98, 95% CI 0.82 to 1.18, p=0.87; overall survival HR 0.91, 95% CI 0.74 to 1.12, p=0.37). In contrast, ever users of selective beta blockers had a significantly higher risk for recurrence and death (progression free survival HR 1.22, 95% CI 1.05 to 1.41, p=0.009; overall survival HR 1.25 95% CI 1.06 to 1.47, p=0.009). In this analysis, co-medication with metformin or statins had no significant impact on survival in patients with primary ovarian cancer. In contrast, co-medication with a beta blocker was associated with worse survival. However, whether this observation is related to the underlying condition rather than a direct negative impact on tumor biology remains unclear.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
生动宛筠发布了新的文献求助10
3秒前
深情安青应助杜一采纳,获得10
4秒前
欢呼傲云发布了新的文献求助10
5秒前
山橘月完成签到,获得积分10
7秒前
8秒前
8秒前
崇林同学完成签到,获得积分10
11秒前
远志完成签到 ,获得积分10
12秒前
13秒前
17秒前
虚幻友瑶完成签到,获得积分10
17秒前
欢呼傲云完成签到,获得积分10
19秒前
xbx1991发布了新的文献求助10
20秒前
杜一发布了新的文献求助10
22秒前
11完成签到 ,获得积分10
25秒前
地德兴完成签到 ,获得积分10
26秒前
27秒前
桐桐应助俊逸海豚采纳,获得10
32秒前
顺心的安珊完成签到 ,获得积分10
35秒前
卡恩完成签到 ,获得积分10
36秒前
英姑应助落叶听风笑采纳,获得10
37秒前
kk完成签到 ,获得积分10
40秒前
SYLH应助火星啵啵采纳,获得10
40秒前
欣喜的鹰发布了新的文献求助20
44秒前
香蕉觅云应助专注的芷蕾采纳,获得10
46秒前
46秒前
杜一完成签到,获得积分20
47秒前
wangchaofk发布了新的文献求助10
47秒前
50秒前
50秒前
50秒前
51秒前
51秒前
哆啦A梦完成签到,获得积分10
54秒前
54秒前
西瓜汁发布了新的文献求助10
54秒前
研友_89eKw8发布了新的文献求助10
54秒前
触摸涨停板完成签到,获得积分0
56秒前
wangchaofk完成签到,获得积分10
57秒前
57秒前
高分求助中
The Mother of All Tableaux Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 2400
Ophthalmic Equipment Market by Devices(surgical: vitreorentinal,IOLs,OVDs,contact lens,RGP lens,backflush,diagnostic&monitoring:OCT,actorefractor,keratometer,tonometer,ophthalmoscpe,OVD), End User,Buying Criteria-Global Forecast to2029 2000
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Cognitive Neuroscience: The Biology of the Mind (Sixth Edition) 1000
Optimal Transport: A Comprehensive Introduction to Modeling, Analysis, Simulation, Applications 800
Official Methods of Analysis of AOAC INTERNATIONAL 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3959900
求助须知:如何正确求助?哪些是违规求助? 3506106
关于积分的说明 11127978
捐赠科研通 3238061
什么是DOI,文献DOI怎么找? 1789483
邀请新用户注册赠送积分活动 871803
科研通“疑难数据库(出版商)”最低求助积分说明 803021